医学
口炎
蘑菇
复发性阿弗他口炎
老虎
还原(数学)
传统医学
皮肤病科
内科学
胃肠病学
作者
Aliza Nur Shuhaili Azlan,Ellysa Teng-Shan Leong,Janet Pei-Shan Chai,Betsy Sara Thomas,Nuruljannah Nor Azmi,Song-Haw Chong,Szu-Ting Ng,Chon-Seng Tan,Shin Yee Fung,Yeannie H. Y. Yap
标识
DOI:10.1615/intjmedmushrooms.2026064928
摘要
Recurrent aphthous stomatitis (RAS) is a common oral mucosal condition characterized by painful ulcerations with no consistently effective treatment. Lignosus rhinocerus (tiger milk mushroom) has been traditionally used in Southeast Asia for its wound-healing and anti-inflammatory properties, yet its clinical application for RAS remains insufficiently studied. This double-blind, randomized clinical trial evaluated the efficacy and safety of an oral gel containing L. rhinocerus TM02® (xLr®) extract in adults with minor RAS. Twenty-one participants aged 20 to 50 years were allocated to placebo gel (n = 6), xLr® gel (n = 7), or Kanolone Oral Base Paste (triamcinolone acetonide 0.1%) (n = 5). All gels were applied three times daily for 7 d. Pain intensity was recorded daily using a visual analog scale (VAS), ulcer diameter was measured on days 1, 3, 5, and 7, and epithelialization was assessed using the 3% hydrogen peroxide test. Kanolone produced the greatest reduction in pain (mean VAS: 2.40) and ulcer size (P ® (mean VAS: 3.10) and placebo (mean VAS: 3.93). The xLr® group demonstrated faster epithelialization (5.4 ± 0.61 d) compared with placebo (6.8 ± 0.40 d) and Kanolone (6.0 ± 0.63 d), although intergroup differences were insignificant. No adverse events were reported across all groups. These findings suggest that xLr® oral gel is safe and exhibits favorable trends in pain reduction and wound epithelialization, supporting ethnomedicinal claims of L. rhinocerus and indicating the need for larger confirmatory trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI